Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2019-10-18

First non-injectable treatment for severe low blood sugar levels

View source ↗

Summary

EMA announces approval of the first non-injectable treatment for severe hypoglycemia, expanding options for management of severe low blood sugar levels.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications